{"title":"Cadonilimab (PD-1/CTLA-4) in combination with lenvatinib in unresectable hepatocellular carcinoma (uHCC): A retrospective real-world study","link":"https://www.sciencedirect.com/science/article/pii/S240584402413647X?dgcid=rss_sd_all","date":null,"content":"<p>Publication date: 15 October 2024</p><p><b>Source:</b> Heliyon, Volume 10, Issue 19</p><p>Author(s): Guosheng Yuan, Yongru Chen, Peilin Zhu, Qiong Deng, Kaiyan Su, Jie Liu, Yan Wang, Rong Li, Wenli Li, Mengya Zang, Xiaoyun Hu, Jun-Jie Wang, Qi Li, Yangfeng Du, Jinzhang Chen</p>","author":"","siteTitle":"ScienceDirect Publication: Heliyon","siteHash":"f7bd7e3f1869707615b3e54fb4ebc4eb7c817c729fd5ad33a7fd4ed65328d468","entryHash":"ee3619e01d30c558ce200bea3dd56086bc5d2604af0085fce02b6d0000b5e4bd","category":"Interdisciplinary"}